C.A. McLaughlin - Concepedia

Author

C.A. McLaughlin

National Institute of Allergy and Infectious Diseases

Also Known As

C A McLaughlin, C. A. McLaughlin, C. McLaughlin, C.A. McLaughlin, Ch. McLaughlin

Publications

298

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health United States Public Health Service Jewish Hospital The University of Osaka

About

C.A. McLaughlin is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, tumor microenvironment, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	200
2	Education	1	1	49
3	Allergy	1	1	49
4	Biochemistry	1	1	36
5	Biomolecular Engineering	1	1	36

C.A. McLaughlin

Publications

285

Citations

H-Index

Page 1

	Year	Citations
Peptides as requirement for immunotherapy of the guinea-pig line-10 tumor with endotoxins E. Ribi, R. Parker, S. Michael Strain, Cancer Immunology Immunotherapy Tumor ImmunologyCancer ImmunosurveillanceImmunologyPathologyPeptide Therapeutic	1979	55
Immune response to porin in cattle immunized with whole cell, outer membrane, and outer membrane protein antigens of Brucella abortus combined with trehalose dimycolate and muramyl dipeptide adjuvants Andrew Winter, D R Verstreate, C. E. Hall, Infection and Immunity Whole CellVeterinary VaccineImmunologyBovine BrucellosisEducation	1983	49
Regression of tumors by an endotoxin combined with trehalose mycolates of differing structure E. Ribi, K. Takayama, K. C. Milner, Cancer Immunology Immunotherapy Microbial ToxinToxinologyTrehalose MycolatesPathologyMedicine	1976	40
The effect of synthetic and naturally occurring trehalose fatty acid esters in tumor regression R. Toubiana, E. Ribi, C.A. McLaughlin, Cancer Immunology Immunotherapy Tumor RegressionBiochemistryLipid NutritionPharmacologyBiomolecular Engineering	1977	36
Comparison of muramyl dipeptide, trehalose dimycolate, and dimethyl dioctadecyl ammonium bromide as adjuvants in Brucella abortus 45/20 vaccines L. F. Woodard, Nancy Toone, C.A. McLaughlin Infection and Immunity	1980	29
Tumor regression induced by defined microbial components in an oil-in-water emulsion is mediated through their binding to oil droplets C.A. McLaughlin, E. Ribi, Mayer B. Goren, Cancer Immunology Immunotherapy BiotechnologyMicroemulsionOil DropletsMicrobiologyDefined Microbial Components	1978	20
Further studies on the structural requirements of agents for immunotherapy of the guinea pig line-10 tumor E. Ribi, R. Toubiana, S. Michael Strain, Cancer Immunology Immunotherapy Cancer ImmunosurveillanceStructural RequirementsMalignant DiseaseFurther StudiesImmunology	1978	20
Moieties of mycobacterial mycolates required for inducing granulomatous reactions C.A. McLaughlin, R. Parker, W. J. Hadlow, Cellular Immunology BacteriologyMycobacterial MycolatesTuberculosisMicrobiologyMedicine	1978	18
Regression of line-10 hepatocellular carcinomas following treatment with water-soluble, microbial extracts combined with trehalose or arabinose mycolates C.A. McLaughlin, S. Michael Strain, W. D. Bickel, Cancer Immunology Immunotherapy HepatologyMedicineLiver PhysiologyHistopathologyPathology	1978	18

Page 1